U.S. FDA Global Offices Update: China Approval Imminent, India On The Horizon
This article was originally published in PharmAsia News
Executive Summary
U.S. FDA is making headway in its efforts to establish U.S. regulatory offices overseas, with final approval in China imminent and a proposal for offices in India in final stages of U.S. approval
You may also be interested in...
U.S. FDA To Open Offices In China As Early As September; India Next
U.S. and China are close to finalizing plans to open U.S. FDA offices in China, and FDA could have "boots on the ground" as early as September, according to Murray Lumpkin, FDA's deputy commissioner for international and special Programs
U.S. FDA To Open Offices In China As Early As September; India Next
U.S. and China are close to finalizing plans to open U.S. FDA offices in China, and FDA could have "boots on the ground" as early as September, according to Murray Lumpkin, FDA's deputy commissioner for international and special Programs
China Government Report On Drug Regulation Seeks To Increase Transparency
BEIJING - As part of a drive to open China's drug regulatory system to public scrutiny and foster international cooperation, the Chinese government has released a ground-breaking report on the current state of its industry oversight